tovecimig
tovecimig: sourced relationships with 1 company · 5 clinical trials tracked.
tovecimig evidence translation
What we can confirm
5 tracked trials
What it means
What to watch
Prepared research question
How could tovecimig → CMPX affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence8 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Compass Therapeutics, Inc. (CMPX) Biliary Tract Cancer; Metastatic Colorectal Cancer | Phase 2 |
Clinical Trial Registry Records (5)
A Phase 2 Clinical Trial of Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
Primary endpoint: Overall Response Rate (ORR)
A Phase IB/II Open-label Study of the Safety and Preliminary Efficacy of CTX-009 Administered Either as a Monotherapy or in Combination With CTX-471 in Patients With Recurrent Glioblastoma
Primary endpoint: Phase IB Arm 1: Toxicity as measured by number of participants with adverse events
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
Primary endpoint: Safety and Adverse Events (AEs)
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel Alone in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers Who Have Received One Prior Systemic Chemotherapy Regimen
Primary endpoint: Best Overall Response
A Phase 2 Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer Who Have Received Two or Three Prior Systemic Chemotherapy Regimens
Primary endpoint: Overall Response Rate
Frequently asked questions
Which companies have sourced relationships with tovecimig?
tovecimig has dated SEC/FDA relationship records for Compass Therapeutics, Inc..
How many clinical trials involve tovecimig?
BioSniper tracks 5 clinical trials involving tovecimig.